a, b, Autoantibodies to DNA and smRNP in the serum (a) and cellular splenic phenotypes (b) from mixed bone marrow chimeric mice containing a 1:1 ratio of control Tlr7+/+CD45.1/Tlr7+/+ CD45.2 or Tlr7+/+CD45.1/Tlr7kik/kikCD45.2 bone marrow. c, Histogram plot and quantification of TLR7 expression in ABCs from Tlr7−/Y (n = 2), Tlr7+/Y (n = 4), Tlr7kik/Y (n = 4) and Tlr7+/Yaa (n = 4) mice. d, Autoantibodies to DNA, RNA and smRNP in the serum from Tlr7−/Y (n = 4), Tlr7+/Y(n = 7), Tlr7kik/Y(n = 5) and Tlr7+/Yaa (n = 5) mice. e, f, Western blot analysis showing splenocyte expression of TLR7 (e) and MyD88 (f) from mice of the indicated genotypes. IB, immunoblot. g, Survival of magnetic-activated cell sorting (MACS)-purified splenic B cells cultured with or without anti-IgM for 72 h from male mice of the indicated genotypes. Data are mean ± s.d. h, Quantification of apoptosis (caspase-3) and proliferation (Ki67) in ABCs from male mice (Tlr7+/Y
n = 8, Tlr7kik/Y
n = 7, Tlr7+/Yaa
n = 7). i, Differentially expressed genes in MACS-purified splenic B cells from wild-type (n = 3) or kika (n = 3) mice cultured with anti-IgM (10 µg ml−1) for 20 h. The bars represent the median values and each dot represents a single mouse. These results are representative of n = 2 (c, e, f, h) or n = 3 (d, g) independent experiments. Experiments in a–e were performed once with n > 25 mice, and experiments in j–n were performed once with n = 4 HC-teens, n = 3 HC-adults and n = 1 patient. Statistical analysis was performed using unpaired t-tests (a); one-way ANOVA with Tukey multiple-comparison test (c, d, h); and two-way ANOVA with Tukey multiple-comparison test (b, g). Exact P values are shown. NS, not significant.